AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2014
May 22, 2014
3174_iss_2014-05-22_f26594ae-f858-4909-932c-d47136e0c79f.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Handelsbanken Fonder AB
Instrument
| Instrument | Aktie SE0003613090 |
|---|---|
| Before the transaction | |
| Shares | 573,967 |
| Voting rights | 573,967 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 21/05/2014 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 608,967 |
| Directly held voting rights | 608,967 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 5.12 % |
| Directly held voting rights | 5.12 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first | ||
| paragraph, line 2 | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | ||
| Group total holdings |
Voting rights 608,967
Percentage of voting rights 5.12
Published
| 22/05/2014 13:54 | ||
|---|---|---|
| Contact | ||
| Name | Katarina Lundborg | |
| Phone | 087011751 | Email [email protected] |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13